Determinants of Diabetes Remission and Glycemic Control after Bariatric Surgery

Diabetes Care

Volumn 39, Issue 1, 2016, Pages 166-174

  Panunzi, Simona ^a   Carlsson, Lena ^b   De Gaetano, Andrea ^a   Peltonen, Markku ^b   Rice, Toni ^c   Sjöström, Lars ^b   Mingrone, Geltrude ^c,d   Dixon, John B ^e  

^a CNR   (Italy)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c CATHOLIC UNIVERSITY   (Italy)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AEROBIC EXERCISE; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CALORIC RESTRICTION; DIET RESTRICTION; DIETARY FIBER; DISEASE DURATION; EARLY INTERVENTION; GASTRIC BANDING; GASTROPLASTY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; LIFESTYLE MODIFICATION; LOW FAT DIET; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PREOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; RESISTANCE TRAINING; ROUX Y ANASTOMOSIS; STOMACH SURGERY; SURGICAL TECHNIQUE; SWEDISH CITIZEN; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; ANALYSIS; DIABETES MELLITUS, TYPE 2; FEMALE; INSULIN RESISTANCE; MALE; MIDDLE AGED; SWEDEN;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; SWEDEN; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 84962124887     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc15-0575     Document Type: Article

References (20)

1. Sjöström L, Lindroos AK, Peltonen M, et al.; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693
2. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012;366:1567-1576
3. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA 2008;299:316-323
4. Schauer PR, BhattDL, Kirwan JP, et al.; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014;370:2002-2013
5. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366:1577-1585
6. Gastrointestinal surgery for severe obesity. Proceedings of a National Institutes of Health Consensus Development Conference. March 25-27, 1991, Bethesda, MD. Am J Clin Nutr 1992;55(2 Suppl.):487S-619S
7. Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: An IDF statement for obese type 2 diabetes. Diabet Med 2011;28:628-642
8. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: A systematic review. JAMA 2013;309:2250-2261
9. Jiménez A, Casamitjana R, Flores L, et al. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects. Ann Surg 2012;256:1023-1029
10. Blackstone R, Bunt JC, Cort és MC, Sugerman HJ. Type 2 diabetes after gastric bypass: Remission in five models using HbA1c, fasting blood glucose, and medication status. Surg Obes Relat Dis 2012;8:548-555
11. Brethauer SA, Aminian A, Romero-Talamás H, et al. Can diabetes be surgically cured? Longterm metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg 2013;258:628-636; discussion 636-637
12. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013;23:93-102
13. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. BMJ 1995;311:158-161
14. Pouliot MC, Despr és JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-468
15. McDermott MM. The international pandemic of chronic cardiovascular disease. JAMA 2007;297:1253-1255
16. Wei M, Gaskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans-a 7-year prospective study. Obes Res 1997;5:16-23
17. Siren R, Eriksson JG, Vanhanen H. Waist circumference a good indicator of future risk for type 2 diabetes and cardiovascular disease. BMC Public Health 2012;12:631
18. Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 2013;36:20-26
19. Dixon JB, Hur KY, Lee WJ, et al. Gastric bypass in Type 2 diabetes with BMI , 30: Weight and weight loss have a major influence on outcomes. Diabet Med 2013;30:e127-e134
20. Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014;311:2297-2304